SIGA TECHNOLOGIES INC (SIGA) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US8269171067
Price
3.14 USD
Market cap
225.66 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
19.11 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–
SIGA TECHNOLOGIES INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 94.57 m USD |
| Gross profit | 64.87 m USD |
| Operating income | 23.70 m USD |
| EBIT | 30.38 m USD |
| Net income | 23.28 m USD |
| Diluted EPS – continuing operations | 0.32 USD |
Full history since 1996, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About SIGA TECHNOLOGIES INC
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. was incorporated in 1995 and is headquartered in New York, New York.
More stocks
- Ceragon Networks Ltd (CRNT)
- Arlandastad Group AB (AGROUP.ST)
- MESABI TRUST (MSB)
- Zona Franca de Iquique S.A (ZOFRI.SN)
- Shanghai Phoenix Enterprise Group Co Ltd B (900916.SS)
- KB Components AB (publ) (KBC.ST)
- Synopex Inc (025320.KQ)
- P2 Gold Inc (PGLD.V)
- ISF GROUP BERHAD (0390.KL)
- Chicago Atlantic Real Estate Finance, Inc. (REFI)
- SuperX AI Technology Limited (SUPX)
- Acadian Timber Corp (ADN.TO)
Not investment advice. All data without warranty, price as of 11.11.2026. Details in the risk notice.